Patents Assigned to C & C Research Laboratories
-
Patent number: 10633394Abstract: A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.Type: GrantFiled: November 30, 2015Date of Patent: April 28, 2020Assignee: C&C RESEARCH LABORATORIESInventors: Chan Hee Park, Sang Hwi Lee, Junhwan Im, Soon Ok Lee, Jungsook Kim, Heon Kyu Park, Jee Hun Yun, Kwang Seok Ko, Hye Jung Kim, Byungho Kim, Mi Sun Kim, Minjung Kong, Hyung Jo Moon
-
Patent number: 10562912Abstract: A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.Type: GrantFiled: June 3, 2014Date of Patent: February 18, 2020Assignee: C&C Research LaboratoriesInventors: Chan Hee Park, Sang Hwi Lee, Junhwan Im, Soon Ok Lee, Hoe Moon Kim, Sung Hyun Moon, Seunghee Kim, Jongmin Kim, Kwang Seok Ko, Bu Young Choi, Byungho Kim
-
Publication number: 20190119297Abstract: A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.Type: ApplicationFiled: November 30, 2015Publication date: April 25, 2019Applicant: C&C RESEARCH LABORATORIESInventors: Chan Hee PARK, Sang Hwi LEE, Junhwan IM, Soon Ok LEE, Jungsook KIM, Heon Kyu PARK, Jee Hun YUN, Kwang Seok KO, Hye Jung KIM, Byungho KIM, Mi Sun KIM, Minjung KONG, Hyung Jo MOON
-
Patent number: 10023591Abstract: A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.Type: GrantFiled: November 30, 2015Date of Patent: July 17, 2018Assignee: C&C RESEARCH LABORATORIESInventors: Chan Hee Park, Sang Hwi Lee, Junhwan Im, Soon Ok Lee, Jongmin Kim, Kwang Seok Ko, Byungho Kim, Minjung Kong, Mi Sun Kim, Hyung Jo Moon
-
Publication number: 20170320889Abstract: A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.Type: ApplicationFiled: November 30, 2015Publication date: November 9, 2017Applicant: C&C RESEARCH LABORATORIESInventors: Chan Hee PARK, Sang Hwi LEE, Junhwan IM, Soon Ok LEE, Jongmin KIM, Kwang Seok KO, Byungho KIM, Minjung KONG, Mi Sun KIM, Hyung Jo MOON
-
Patent number: 9586959Abstract: The present invention relates to novel heterocyclic compounds of formula 1 useful in preparing drugs for treatment of diseases associated with various functions of the histamine 4 receptor. Especially, the said drugs are useful for treatment of inflammatory diseases, allergy, pain, nasal polyps, rhinitis, chronic sinusitis, nasal congestion, nasal itch, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, eczema, pruritus, itchy skin, urticaria, idiopathic chronic urticaria, scleroderma, conjunctivitis, keratoconjunctivitis, ocular inflammation, dry eye, cardiac dysfunction, arrhythmia, atherosclerosis, multiple sclerosis, inflammatory bowel disease (including colitis, Crohn's disease, ulcerative colitis), inflammatory pain, neuropathic pain, osteoarthritic pain, autoimmune thyroid disease, immune-mediated (also known as type I) diabetes, lupus, post-operative adhesions, vestibular disorders and cancer.Type: GrantFiled: September 28, 2012Date of Patent: March 7, 2017Assignee: C&C RESEARCH LABORATORIESInventors: Pil Su Ho, Dong Oh Yoon, Sun Young Han, Won Il Lee, Jung Sook Kim, Woul Seong Park, Sung Oh Ahn, Hye Jung Kim
-
Publication number: 20140315888Abstract: The present invention relates to novel heterocyclic compounds useful in preparing drugs for treatment of diseases associated with various functions of the histamine 4 receptor. Especially, the said drugs are useful for treatment of inflammatory diseases, allergy, pain, nasal polyps, rhinitis, chronic sinusitis, nasal congestion, nasal itch, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, eczema, pruritus, itchy skin, urticaria, idiopathic chronic urticaria, scleroderma, conjunctivitis, keratoconjunctivitis, ocular inflammation, dry eye, cardiac dysfunction, arrhythmia, atherosclerosis, multiple sclerosis, inflammatory bowel disease (including colitis, Crohn's disease, ulcerative colitis), inflammatory pain, neuropathic pain, osteoarthritic pain, autoimmune thyroid disease, immune-mediated (also known as type I) diabetes, lupus, post-operative adhesions, vestibular disorders and cancer.Type: ApplicationFiled: September 28, 2012Publication date: October 23, 2014Applicant: C&C RESEARCH LABORATORIESInventors: Pil Su Ho, Dong Oh Yoon, Sun Young Han, Won Il Lee, Jung Sook Kim, Woul Seong Park, Sung Oh Ahn, Hye Jung Kim
-
Patent number: 8394792Abstract: Disclosed are heterocyclic derivatives, and more particularly heterocyclic derivatives having the following Formula I which are useful for the preparation of medicaments for treating diseases related to uric acid: wherein R1, R2, R3, R4, R5, R6, R7, R8, X1, X2, X3, L and Y are the same as defined in the detailed description.Type: GrantFiled: March 31, 2009Date of Patent: March 12, 2013Assignee: C&C Research LaboratoriesInventors: Sung Oh Ahn, Chan Hee Park, Jun Hwan Im, Soon Ok Lee, Kyoung June Lee, Seong Wook Cho, Kwang Seok Ko, Sun Young Han, Won Il Lee
-
Patent number: 6201006Abstract: The present invention relates to a novel thrombin inhibitor which is effective even when orally administered. More specifically, the present invention relates to an aromatic amidine derivative represented by formula (I) and the salts thereof, which show potent selective inhibitory activity for thrombin in which (a), R, R1, R2, R3, A, W, Y and n are defined as described in the specification.Type: GrantFiled: November 13, 1998Date of Patent: March 13, 2001Assignee: C & C Research LaboratoriesInventors: Bon Am Koo, Jae Ki Min, Woo Sang Hong, Eun Jung Ryu, Woong Hyun Nam, Jong Min Kim
-
Patent number: 6153768Abstract: The present invention relates to a novel benzopyran derivative having anti-estrogenic activity.Type: GrantFiled: June 8, 1999Date of Patent: November 28, 2000Assignee: C & C Research LaboratoriesInventors: Jae Chon Jo, Sung Dae Park, Hyun Suk Lim, Ju Su Kim, Sung Jin Kim, Kazumi Morikawa, Yoshitake Kanbe, Masahiro Nishimoto, Myung-Hwa Kim